Law Offices of Gary Martin Hays & Associates
P.C.
75 Ponce De Leon Ave NE Ste 101
Atlanta,
GA 30308(470) 294-1674
www.garymartinhays.com
By Kat Black | June 11, 2024
A $700 million settlement reached by Johnson & Johnson with attorneys general from 43 states prohibits the pharmaceutical company from manufacturing, selling or distributing its talcum-based body powder products, which are known to increase the risk for cancer, in the United States.
By Colleen Murphy | June 11, 2024
Counsel for Sun Pharmaceutical and Ranbaxy, Devora W. Allon, a partner with Kirkland & Ellis in New York, said that the plaintiffs hired a regulatory expert to say that the Food and Drug Administration moves as fast as it can and that if there had been an earlier target date, the FDA would have met that date.
By Charles Toutant | May 30, 2024
Five of the suits were filed by Esperion Therapeutics, which seeks to stop competitors from selling generic versions of the company's cholesterol drug Nexletol.
By Marianna Wharry | May 28, 2024
Pfizer recently filed seven lawsuits in federal court seeking to enjoin multiple multinational pharmaceutical companies from selling a generic version of its medication, Nurtec, which is used to prevent and treat migraines.
By Charles Toutant | May 13, 2024
ZHP sought to invoke the Apex Doctrine, which seeks to limit depositions of individuals at the "apex" of a corporation based on the premise that lower-level employees are likely to have firsthand knowledge of the material facts, and that deposing the top executives of a corporation is likely to impose a significant burden.
By Colleen Murphy | May 6, 2024
"In a ruling from the bench, Judge Hurd concluded that 'at the end of the day it's not a question of admissibility, it's a question of is it reasonably calculated to lead to the discovery of admissible evidence under Rule 4:10- 2," the opinion said.
By Brian Lee | May 3, 2024
The settlement in principle accounts for New Jersey-based Amneal's role in fueling the national epidemic of opioid addictions and overdoses, New York and California said in separate statements.
By Maria Dinzeo | April 18, 2024
Heidi Chen spent 13 years at Pfizer before she helped spin out the company's animal-health business into a stand-alone public company in 2012 and became its first legal chief.
By Charles Toutant | April 15, 2024
"It's called an unapproved drug. It's a drug in other countries, this tianeptine, used for an antidepressant. But it's never been approved in America, and I think it's falling through the regulatory cracks," plaintiff attorney Michael Pender said.
By Riley Brennan | April 2, 2024
This suit was surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
Gill & Chamas, LLC seeks a Personal Injury attorney to work in their Woodbridge, NJ office. Candidate must possess the following: ...
We are seeking an attorney with a minimum of four years of experience in transactional work to join our well-established, nationally renowne...